Bio-Tek Research Consultants Durham, NC - 27713

Bio-Tek Research Consultants is categorized under Pathological Laboratories in Durham, NC .

Bio-Tek Research Consultants was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6215112 by the NAICS.

If you are seeking more information, feel free to contact Letia Dean, Owner at the company’s single location by writing to 4202 South Alston Avenue, Durham, North Carolina NC 27713 or by phoning (919) 361-2128. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bio-Tek Research Consultants
Contact Person: Letia Dean, Owner
Address: 4202 South Alston Avenue, Durham, North Carolina 27713
Phone Number: (919) 361-2128
Website Address: btrc.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Pathological Laboratories
SIC Code: 8071
NAICS Code: 6215112
Share This Business:

Bio-Tek Research Consultants was started in 0 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6215112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Letia Dean, Owner for inquiries that concern Bio-Tek Research Consultants by calling the company number (919) 361-2128, as your correspondence is most welcome. Additionally, the physical location of the single location of Bio-Tek Research Consultants can be found at the coordinates 35.91494,-78.88888 as well as the street address 4202 South Alston Avenue in Durham, North Carolina 27713.

For its online presence, you may visit Bio-Tek Research Consultants’s website at btrc.com and engage with its social media outlets through on Twitter and on Facebook.